Subgroup analysis of mortality rate based on surgery type. by Mohamed R. Abdelraouf (21501468)

Subjects:

Funnel plot of Creatinine level outcome (Egger test = p-value = 0.1632). by Mohamed R. Abdelraouf (21501468)

Subjects:

All data points from Fig 6. by Sara Hijazi (21656615)

Subjects:

Bar chart showing the mean age at first menstruation across Indian states for the years 1992–93 and 2019–21. by MD. Nahid Hassan Nishan (22264861)

Subjects:

PRV UL4 augments ASC oligomerization and speck formation. by Xiaohua Zhang (350570)

Subjects:

Subgroup analysis of BUN based on surgery type. by Mohamed R. Abdelraouf (21501468)

Subjects:

The ROC curves and AUC values of the diagnostic model. by Zhe Wu (582498)

Subjects:

Subgroup analysis of Hospital Stay based on surgery type. by Mohamed R. Abdelraouf (21501468)

Subjects:

PRV UL4 interacts with ASC. by Xiaohua Zhang (350570)

Subjects:

Estimates of the average yearly citations per publication (including all publications) by scholar group, misconduct type, and time. by Giulia Maimone (20833354)

Subjects:

Funnel plot of ALT level outcome (Egger test = p-value = 0.5918). by Mohamed R. Abdelraouf (21501468)

Subjects:

Subgroup analysis of Lactate level based on pump type. by Mohamed R. Abdelraouf (21501468)

Subjects:

Effects of HFCS and hazelnut on biochemical parameters in groups of rats. by Ayça Toprak-Semiz (22582110)

Subjects:

Adult demyelination has no effect on PV interneuron’s firing rate or failures in autaptic responses. by Sara Hijazi (21656615)

Subjects:

Autapses play a crucial role in PV interneuron’s sustained firing at high frequencies. by Sara Hijazi (21656615)

Subjects:

The UL4 null mutation alleviates inflammasome activation in PRV-infected cells. by Xiaohua Zhang (350570)

Subjects:

Baseline Characteristics of Included Patients. by Mohamed R. Abdelraouf (21501468)

Subjects:

Subgroup analysis of Inotropic use based on pump type. by Mohamed R. Abdelraouf (21501468)

Subjects:

NIE ELISA results. by Jannet A. Tobon Ramos (20855642)

“…Twelve months post-MDA, hookworm prevalence decreased to 56.5% in DA- and 34.4% in IDA-treated villages, respectively (<i>p</i><0.001, both comparisons). …”

Kato Katz and PCR database 12 months collection. by Jannet A. Tobon Ramos (20855642)

“…Twelve months post-MDA, hookworm prevalence decreased to 56.5% in DA- and 34.4% in IDA-treated villages, respectively (<i>p</i><0.001, both comparisons). …”